# OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
> **ANDA077528** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2012-06-19
## Drug
- **FDA Application Number:** ANDA077528
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE AND FLUOXETINE HYDROCHLORIDE
- **Generic name:** OLANZAPINE AND FLUOXETINE
- **Active ingredients:** FLUOXETINE HYDROCHLORIDE; OLANZAPINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2012-06-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077528)
---
*MORVS · CC0 1.0*